Literature DB >> 29135382

Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities.

Gaia Rizzo1, Mattia Veronese2, Matteo Tonietto3, Benedetta Bodini3,4, Bruno Stankoff3,4,5, Catriona Wimberley5, Sonia Lavisse6,7, Michel Bottlaender5,8, Peter S Bloomfield9, Oliver Howes9,10, Paolo Zanotti-Fregonara11, Federico E Turkheimer2, Alessandra Bertoldo1,12.   

Abstract

The 18 kDa translocator protein (TSPO) is a marker of microglia activation and the main target of positron emission tomography (PET) ligands for neuroinflammation. Previous works showed that accounting for TSPO endothelial binding improves PET quantification for [11C]PBR28, [18F]DPA714 and [11C]-R-PK11195. It is still unclear, however, whether the vascular signal is tracer-dependent. This work aims to explore the relationship between the TSPO vascular and tissue components for PET tracers with varying affinity, also assessing the impact of affinity towards the differentiability amongst kinetics and the ensuing ligand amenability to cluster analysis for the extraction of a reference region. First, we applied the compartmental model accounting for vascular binding to [11C]-R-PK11195 data from six healthy subjects. Then, we compared the [11C]-R-PK11195 vascular binding estimates with previously published values for [18F]DPA714 and [11C]PBR28. Finally, we determined the suitability for reference region extraction by calculating the angle between grey and white matter kinetics. Our results showed that endothelial binding is common to all TSPO tracers and proportional to their affinity. By consequence, grey and white matter kinetics were most similar for the radioligand with the highest affinity (i.e. [11C]PBR28), hence poorly suited for the extraction of a reference region using supervised clustering.

Entities:  

Keywords:  Translocator protein; [C]-R-PK11195; [C]PBR28; [F]DPA714; clustering; endothelium; kinetic modelling; microglia; neuroinflammation; reference region

Mesh:

Substances:

Year:  2017        PMID: 29135382      PMCID: PMC6501510          DOI: 10.1177/0271678X17742004

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  Physical characteristics of the ECAT EXACT3D positron tomograph.

Authors:  T J Spinks; T Jones; P M Bloomfield; D L Bailey; M Miller; D Hogg; W F Jones; K Vaigneur; J Reed; J Young; D Newport; C Moyers; M E Casey; R Nutt
Journal:  Phys Med Biol       Date:  2000-09       Impact factor: 3.609

2.  Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts.

Authors:  N Soreni; A Apter; A Weizman; O Don-Tufeled; S Leschiner; L Karp; M Gavish
Journal:  Biol Psychiatry       Date:  1999-08-15       Impact factor: 13.382

3.  The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker.

Authors:  Andrew Lockhart; Bill Davis; Julian C Matthews; Hassan Rahmoune; Guizhu Hong; Antony Gee; David Earnshaw; John Brown
Journal:  Nucl Med Biol       Date:  2003-02       Impact factor: 2.408

4.  Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms.

Authors:  Stefano Pini; Claudia Martini; Marianna Abelli; Matteo Muti; Camilla Gesi; Marina Montali; Beatrice Chelli; Antonio Lucacchini; Giovanni B Cassano
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 5.  The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development.

Authors:  Leo Veenman; Moshe Gavish
Journal:  Pharmacol Ther       Date:  2005-12-07       Impact factor: 12.310

6.  Peripheral benzodiazepine binding sites in platelets of patients affected by mitochondrial diseases and large scale mitochondrial DNA rearrangements.

Authors:  Claudia Martini; Beatrice Chelli; Laura Betti; Marina Montali; Michelangelo Mancuso; Gino Giannaccini; Anna Rocchi; Luigi Murri; Gabriele Siciliano
Journal:  Mol Med       Date:  2002-12       Impact factor: 6.354

7.  Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients.

Authors:  Michael Ritsner; Ilan Modai; Anatoly Gibel; Svetlana Leschiner; Henry Silver; German Tsinovoy; Abraham Weizman; Moshe Gavish
Journal:  J Psychiatr Res       Date:  2003 Nov-Dec       Impact factor: 4.791

8.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies.

Authors:  Federico E Turkheimer; Paul Edison; Nicola Pavese; Federico Roncaroli; Alexander N Anderson; Alexander Hammers; Alexander Gerhard; Rainer Hinz; Yan F Tai; David J Brooks
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

9.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

Authors:  R B Banati; J Newcombe; R N Gunn; A Cagnin; F Turkheimer; F Heppner; G Price; F Wegner; G Giovannoni; D H Miller; G D Perkin; T Smith; A K Hewson; G Bydder; G W Kreutzberg; T Jones; M L Cuzner; R Myers
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

10.  Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe.

Authors:  Alexander Hammers; Richard Allom; Matthias J Koepp; Samantha L Free; Ralph Myers; Louis Lemieux; Tejal N Mitchell; David J Brooks; John S Duncan
Journal:  Hum Brain Mapp       Date:  2003-08       Impact factor: 5.038

View more
  22 in total

1.  Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate.

Authors:  Nadja Van Camp; Yaël Balbastre; Anne-Sophie Herard; Sonia Lavisse; Clovis Tauber; Catriona Wimberley; Martine Guillermier; Aurélie Berniard; Pauline Gipchtein; Caroline Jan; Romina Aron Badin; Thierry Delzescaux; Philippe Hantraye; Gilles Bonvento
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-25       Impact factor: 6.200

2.  Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET.

Authors:  Valeria T Barletta; Elena Herranz; Costantina A Treaba; Russell Ouellette; Ambica Mehndiratta; Marco L Loggia; Eric C Klawiter; Carolina Ionete; Sloane A Jacob; Caterina Mainero
Journal:  Mult Scler       Date:  2019-04-11       Impact factor: 6.312

3.  Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.

Authors:  Benedetta Bodini; Emilie Poirion; Matteo Tonietto; Charline Benoit; Raffaele Palladino; Elisabeth Maillart; Erika Portera; Marco Battaglini; Geraldine Bera; Bertrand Kuhnast; Céline Louapre; Michel Bottlaender; Bruno Stankoff
Journal:  J Nucl Med       Date:  2020-01-31       Impact factor: 10.057

4.  Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects.

Authors:  Zhen Fan; Melanie Dani; Grazia D Femminella; Melanie Wood; Valeria Calsolaro; Mattia Veronese; Federico Turkheimer; Steve Gentleman; David J Brooks; Rainer Hinz; Paul Edison
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

5.  Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using 11C-PBR28.

Authors:  Paolo Zanotti-Fregonara; William C Kreisl; Robert B Innis; Chul Hyoung Lyoo
Journal:  J Nucl Med       Date:  2019-01-17       Impact factor: 10.057

Review 6.  The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia.

Authors:  Sovannarath Pong; Rakesh Karmacharya; Marianna Sofman; Jeffrey R Bishop; Paulo Lizano
Journal:  Complex Psychiatry       Date:  2020-09-14

7.  Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.

Authors:  Emilie Poirion; Matteo Tonietto; François-Xavier Lejeune; Vito A G Ricigliano; Marine Boudot de la Motte; Charline Benoit; Géraldine Bera; Bertrand Kuhnast; Michel Bottlaender; Benedetta Bodini; Bruno Stankoff
Journal:  Neurology       Date:  2021-03-18       Impact factor: 9.910

Review 8.  What value can TSPO PET bring for epilepsy treatment?

Authors:  Viviane Bouilleret; Stefanie Dedeurwaerdere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-12       Impact factor: 9.236

9.  A binge high sucrose diet provokes systemic and cerebral inflammation in rats without inducing obesity.

Authors:  Omkar L Patkar; Abdalla Z Mohamed; Ashwin Narayanan; Karine Mardon; Gary Cowin; Rajiv Bhalla; Damion H R Stimson; Michael Kassiou; Kate Beecher; Arnauld Belmer; Ignatius Alvarez Cooper; Michael Morgan; David A Hume; Katharine M Irvine; Selena E Bartlett; Fatima Nasrallah; Paul Cumming
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

10.  Parametric Mapping for TSPO PET Imaging with Spectral Analysis Impulsive Response Function.

Authors:  Mattia Veronese; Marcello Tuosto; Tiago Reis Marques; Oliver Howes; Belen Pascual; Meixiang Yu; Joseph C Masdeu; Federico Turkheimer; Alessandra Bertoldo; Paolo Zanotti-Fregonara
Journal:  Mol Imaging Biol       Date:  2021-01-21       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.